
OLD Category: immuno-oncology
February 23, 2019 / Ann Oncol.
Context matters—consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials
February 15, 2019 / Clin Cancer Res
ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment
February 8, 2019 / Hum Gene Ther.
Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response
February 7, 2019 / Ann Oncol.
The immune profile of small HER2-positive breast cancers: a secondary analysis from the APT trial
February 6, 2019 / J Immunother Cancer
Prognostic value of CD8 + PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancer
February 4, 2019 / Visc Med
Immunologic Biomarkers and Biomarkers for Immunotherapies in Gastrointestinal Cancer
February 1, 2019 / Gene Ther.
Characterization of abscopal effects of intratumoral electroporation-mediated IL-12 gene therapy
February 1, 2019 / Immunol Cell Biol.
The immune checkpoint CD96 defines a distinct lymphocyte phenotype and is highly expressed on tumor‐infiltrating T cells
February 1, 2019 / Clin Cancer Res
Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell Carcinoma
January 31, 2019 / Gastroenterology